Form 8-K - Current report:
SEC Accession No. 0001193125-24-011701
Filing Date
2024-01-22
Accepted
2024-01-22 08:01:09
Documents
55
Period of Report
2024-01-22
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d735106d8k.htm   iXBRL 8-K 29119
2 EX-99.1 d735106dex991.htm EX-99.1 60996
7 GRAPHIC g735106ex99_1p10g1.jpg GRAPHIC 353372
8 GRAPHIC g735106ex99_1p11g1.jpg GRAPHIC 212225
9 GRAPHIC g735106ex99_1p12g1.jpg GRAPHIC 245455
10 GRAPHIC g735106ex99_1p13g1.jpg GRAPHIC 345133
11 GRAPHIC g735106ex99_1p14g1.jpg GRAPHIC 328993
12 GRAPHIC g735106ex99_1p15g1.jpg GRAPHIC 329976
13 GRAPHIC g735106ex99_1p16g1.jpg GRAPHIC 357639
14 GRAPHIC g735106ex99_1p17g1.jpg GRAPHIC 292921
15 GRAPHIC g735106ex99_1p18g1.jpg GRAPHIC 258011
16 GRAPHIC g735106ex99_1p19g1.jpg GRAPHIC 304643
17 GRAPHIC g735106ex99_1p1g1.jpg GRAPHIC 384822
18 GRAPHIC g735106ex99_1p20g1.jpg GRAPHIC 222747
19 GRAPHIC g735106ex99_1p21g1.jpg GRAPHIC 283163
20 GRAPHIC g735106ex99_1p22g1.jpg GRAPHIC 225086
21 GRAPHIC g735106ex99_1p23g1.jpg GRAPHIC 389183
22 GRAPHIC g735106ex99_1p24g1.jpg GRAPHIC 282270
23 GRAPHIC g735106ex99_1p25g1.jpg GRAPHIC 390937
24 GRAPHIC g735106ex99_1p26g1.jpg GRAPHIC 266396
25 GRAPHIC g735106ex99_1p27g1.jpg GRAPHIC 368273
26 GRAPHIC g735106ex99_1p28g1.jpg GRAPHIC 266580
27 GRAPHIC g735106ex99_1p29g1.jpg GRAPHIC 454652
28 GRAPHIC g735106ex99_1p2g1.jpg GRAPHIC 774653
29 GRAPHIC g735106ex99_1p30g1.jpg GRAPHIC 382660
30 GRAPHIC g735106ex99_1p31g1.jpg GRAPHIC 347116
31 GRAPHIC g735106ex99_1p32g1.jpg GRAPHIC 354113
32 GRAPHIC g735106ex99_1p33g1.jpg GRAPHIC 357916
33 GRAPHIC g735106ex99_1p34g1.jpg GRAPHIC 256291
34 GRAPHIC g735106ex99_1p35g1.jpg GRAPHIC 380345
35 GRAPHIC g735106ex99_1p36g1.jpg GRAPHIC 258349
36 GRAPHIC g735106ex99_1p37g1.jpg GRAPHIC 253023
37 GRAPHIC g735106ex99_1p38g1.jpg GRAPHIC 278127
38 GRAPHIC g735106ex99_1p39g1.jpg GRAPHIC 344013
39 GRAPHIC g735106ex99_1p3g1.jpg GRAPHIC 489583
40 GRAPHIC g735106ex99_1p40g1.jpg GRAPHIC 407359
41 GRAPHIC g735106ex99_1p41g1.jpg GRAPHIC 443717
42 GRAPHIC g735106ex99_1p4g1.jpg GRAPHIC 342805
43 GRAPHIC g735106ex99_1p5g1.jpg GRAPHIC 330649
44 GRAPHIC g735106ex99_1p6g1.jpg GRAPHIC 354165
45 GRAPHIC g735106ex99_1p7g1.jpg GRAPHIC 358757
46 GRAPHIC g735106ex99_1p8g1.jpg GRAPHIC 365298
47 GRAPHIC g735106ex99_1p9g1.jpg GRAPHIC 279946
  Complete submission text file 0001193125-24-011701.txt   19453529

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nams-20240122.xsd EX-101.SCH 4332
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nams-20240122_def.xml EX-101.DEF 13670
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nams-20240122_lab.xml EX-101.LAB 22801
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nams-20240122_pre.xml EX-101.PRE 14638
49 EXTRACTED XBRL INSTANCE DOCUMENT d735106d8k_htm.xml XML 5635
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41562 | Film No.: 24547116
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)